Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

155
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
155
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

198
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
198
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.5K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.5K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

189
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
189
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

522
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
522
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

152
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND).

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Development and validation of a cephalic conformation scoring system for the domestic rabbit (Oryctolagus cuniculus).

The Veterinary record·2026
Same author

Parasitic infection and resource acquisition shape senescence through oxidative stress and energy depletion.

Evolution; international journal of organic evolution·2026
Same author

Correction: 'Variable efficacy of praziquantel among Schistosoma-infected ruminants of northern Senegal-a drug trial and population genetic study across two contrasting epidemiological regions' (2026), by Diaz et al.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
Same author

TRPtracker: a community database for monitoring praziquantel sensitivity at TRPM<sub>PZQ</sub> variants.

International journal for parasitology. Drugs and drug resistance·2026
Same author

Onchocerca volvulus infection prevalence and intensity in Logo and Nyarambe Health Zones in Ituri, Democratic Republic of the Congo in 2010 and in 2021-2023: results of screening for clinical trials of moxidectin versus ivermectin.

Parasites & vectors·2026

Related Experiment Video

Updated: Nov 8, 2025

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
20:36

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 4, 2007

9.0K

Supporting Drug Development for Neglected Tropical Diseases Using Mathematical Modeling.

Martin Walker1,2, Jonathan I D Hamley2, Philip Milton2

  • 1Department of Pathobiology and Population Sciences and London Centre for Neglected Tropical Disease Research, Royal Veterinary College, Hatfield, United Kingdom.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|April 24, 2021
PubMed
Summary

Mathematical modeling can optimize drug development for neglected tropical diseases, ensuring efficient resource allocation. This approach aids in refining drug targets and clinical trial designs for disease elimination strategies.

Keywords:
drug developmentfilariasesmathematical modelingneglected tropical diseasesonchocerciasis

More Related Videos

Chemical Cartography Approaches to Study Trypanosomatid Infection
08:21

Chemical Cartography Approaches to Study Trypanosomatid Infection

Published on: January 21, 2022

2.5K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

658

Related Experiment Videos

Last Updated: Nov 8, 2025

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
20:36

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 4, 2007

9.0K
Chemical Cartography Approaches to Study Trypanosomatid Infection
08:21

Chemical Cartography Approaches to Study Trypanosomatid Infection

Published on: January 21, 2022

2.5K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

658

Area of Science:

  • Neglected Tropical Diseases (NTDs)
  • Mathematical Modeling in Public Health
  • Drug Development Strategy

Background:

  • Preventive chemotherapy is crucial for eliminating 5 major NTDs: trachoma, soil-transmitted helminthiases, schistosomiasis, lymphatic filariasis, and onchocerciasis.
  • Current drug interventions show promise for some NTDs, but novel therapeutics are increasingly recognized as necessary, particularly for onchocerciasis.
  • The high cost and low return on investment in NTD drug development necessitate efficient resource utilization.

Purpose of the Study:

  • To demonstrate how mathematical modeling can guide drug development for NTDs.
  • To illustrate resource-saving and efficiency gains in drug development through modeling.
  • To inform the refinement of target product profiles, intended use, and clinical trial design for NTD interventions.

Main Methods:

  • Utilized illustrative results from mathematical modeling.
  • Applied modeling to various stages of the drug development pathway.
  • Focused on guiding decisions from target product profiles to clinical trial design.

Main Results:

  • Mathematical modeling provides a framework for optimizing drug development investments.
  • Modeling can lead to significant resource savings and efficiency improvements.
  • The approach helps refine target product profiles and clinical trial strategies for NTDs.

Conclusions:

  • Mathematical modeling is a valuable tool for efficient drug development in the context of NTDs.
  • Strategic application of modeling can enhance the likelihood of achieving NTD elimination goals.
  • Optimized drug development pathways are essential for maximizing the impact of limited resources in global health initiatives.